Heart Disease News and Research

Latest Heart Disease News and Research

UT Southwestern launches telemedicine program to extend stroke care to patients in rural areas

UT Southwestern launches telemedicine program to extend stroke care to patients in rural areas

Bariatric surgery more effective than intensive medical therapy for managing type 2 diabetes

Bariatric surgery more effective than intensive medical therapy for managing type 2 diabetes

Binghamton University receives HEARTSafe Campus accreditation from NCEMSF

Binghamton University receives HEARTSafe Campus accreditation from NCEMSF

Men with long-term HIV infections at higher risk of developing plaque in their coronary arteries

Men with long-term HIV infections at higher risk of developing plaque in their coronary arteries

Young adults with cardiac risk factors have worse cognitive function in middle age

Young adults with cardiac risk factors have worse cognitive function in middle age

Cognitive deficits in bipolar patients ‘not homogenous’

Cognitive deficits in bipolar patients ‘not homogenous’

Bariatric surgery patients report better quality of life

Bariatric surgery patients report better quality of life

Enrollment commences for Daiichi Sankyo's ENSURE-AF multinational phase 3 study in NVAF patients

Enrollment commences for Daiichi Sankyo's ENSURE-AF multinational phase 3 study in NVAF patients

Amgen reports positive findings from AMG 145 Phase 3 studies in patients at risk for cardiovascular disease

Amgen reports positive findings from AMG 145 Phase 3 studies in patients at risk for cardiovascular disease

Genetic markers could help predict heart attack in patients with heart disease

Genetic markers could help predict heart attack in patients with heart disease

Pfizer issues statement on FDA approval of non-prescription drug, Nexium 24HR

Pfizer issues statement on FDA approval of non-prescription drug, Nexium 24HR

SEATTLE II study confirms safety and efficacy of thrombolytic therapy for acute PE

SEATTLE II study confirms safety and efficacy of thrombolytic therapy for acute PE

Researchers quantify proportion of adults potentially affected by updated 2014 BP recommendations

Researchers quantify proportion of adults potentially affected by updated 2014 BP recommendations

Cheap drug holds promise of treating heart attack patients

Cheap drug holds promise of treating heart attack patients

Newly identified protein markers have potential to contribute to better understanding of heart disease

Newly identified protein markers have potential to contribute to better understanding of heart disease

Mechanical circulatory assist device may have untapped potential in heart surgery patients, say physicians

Mechanical circulatory assist device may have untapped potential in heart surgery patients, say physicians

MADIT-CRT study: Boston Scientific CRT defibrillator reduces risk of death in mild heart failure patients

MADIT-CRT study: Boston Scientific CRT defibrillator reduces risk of death in mild heart failure patients

Study on effects of cholesterol-lowering medications on sexual health

Study on effects of cholesterol-lowering medications on sexual health

Setting clocks ahead 1 hour may accelerate cardiac events in some, shows study

Setting clocks ahead 1 hour may accelerate cardiac events in some, shows study

Aleglitazar drug does not reduce risk of cardiovascular events in patients with type 2 diabetes

Aleglitazar drug does not reduce risk of cardiovascular events in patients with type 2 diabetes

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.